⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 13, 2024

Supplementary Figure S3 from Mutant IDH Modulates Suppressive Myeloid Populations in Malignant Glioma

Eric P. Grewal Leland G. Richardson Jing Sun Rishab Ramapriyan Maria Martinez‐Lage Julie J. Miller Bob S. Carter Daniel P. Cahill William T. Curry Bryan D. Choi

View at Publisher

Ask AI

Bookmark

Share

Abstract

Supplementary Figure 3. Effect of IDH inhibition on intratumoral macrophage population in murine IDH-mutant glioma

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Grewal et al. (2024) studied this question.

synapsesocial.com/papers/68e58a5ab6db64358752636d https://doi.org/10.1158/1078-0432.27013708.v1

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S3 from Mutant IDH Modulates Suppressive Myeloid Populations in Malignant Glioma2024
2Supplementary Figure S2 from Mutant IDH Modulates Suppressive Myeloid Populations in Malignant Glioma2024
3Supplementary Figure S2 from Mutant IDH Modulates Suppressive Myeloid Populations in Malignant Glioma2024
4Supplementary Figure S1 from Mutant IDH Modulates Suppressive Myeloid Populations in Malignant Glioma2024
5Supplementary Figure S1 from Mutant IDH Modulates Suppressive Myeloid Populations in Malignant Glioma2024

More related papers

Data from Mutant IDH Modulates Suppressive Myeloid Populations in Malignant Glioma2024
Supplementary Figure S9: from (R)-2-hydroxyglutarate inhibits KDM5 histone lysine demethylases to drive transformation in IDH-mutant cancers2024
Supplementary Figure S9: from (R)-2-hydroxyglutarate inhibits KDM5 histone lysine demethylases to drive transformation in IDH-mutant cancers2024